[1]
O. I. Kocherzhat, “EVALUATION OF MARKERS OF TARGET ORGANS PRECLINICAL DAMAGE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMBINED WITH METABOLIC SYNDROME DEPENDING ON THE OBESITY STAGE”, East. Ukr. Med. J., vol. 7, no. 2, pp. 142–147, Jun. 2019.